BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 5, 2003
View Archived Issues
Repligen Raises $12.5 Privately To Advance Secretin Program
Repligen Corp. raised $12.5 million through a private placement and will use the funds in part for its Phase III product, secretin, also called RG1068. (BioWorld Today)
Read More
RNA Tools Company Ambion Gets $10.5 Million In Private Placement
Read More
Pennsylvania Team Makes Eggs,Seems To Abrogate Sacrosanct Embryonic Stem Cells Barrier
Read More
Strong, Predictable Patent Office Needed By Biotech, Pharma Firms
Read More
Other News To Note
Read More
Appointments And Advancements
Read More